Cardiovascular Research Institute
Search this site:
Advanced Search
Edward F. Terrien, MD, FACC
Departments & Services > Cardiovascular Research Institute > Participants > Edward F. Terrien, MD, FACC  

Doctor/Provider Search
Maps & Directions
This Week's Events
Online Medical Information
Departments & Services
UVM College of Medicine





Print page

Edward F. Terrien, MD, FACC

Edward F. Terrien, MD, FACC

Education:

Medical School
University of Vermont, Burlington, VT

Training:

Residency
Duke University Medical Center, Durham, NC
Fellowship
William Beaumont Hospital, Royal Oak, MI

Specialty:

Coronary Intervention
Cardiac Catheterization
Ischemic Heart Disease
Peripheral Vascular Intervention

Certifications:

Internal Medicine
Cardiovascular Disease
Interventional Cardiology

Academic Appointments:

Associate Professor of Medicine, University of Vermont

Biography:

A specialist in cardiovascular intervention and ischemic heart disease, Dr. Terrien has been the principal investigator for multi-center trials of novel therapeutics such as in PRESTO and SAFER at Fletcher Allen Health Care. Dr. Terrien is a dedicated and tireless clinician and excellent teacher. Dr Terrien is a native of Vermont and earned both his undergraduate and medical degrees at the University of Vermont. He lives in Colchester with his wife, a nurse, and two daughters.

Major Research Interests:

Publications:

Bowers TR, Terrien EF, O'Neill WW, Sachs D, Grines CL. Effect of reperfusion modality on outcome in nonsmokers and smokers with acute myocardial infarction (a Primary Angioplasty in Myocardial Infarction [PAMI] substudy). PAMI Investigators.  Am J Cardiol 1996; 78:511-515.

Timmis GC, Terrien E. The treatment of myocardial infarction.  J Interv Cardiol 1995; 8(6 Suppl):730-751.

Franklin BA, Hogan P, Bonzheim K, Bakalyar D, Terrien E, Gordon S, Timmis GC.  Cardiac demands of heavy snow shoveling.  JAMA 1995; 273:880-882.

Kabbani SS, Watkins MW, Ashikaga T, Terrien EF, Holoch PA, Sobel BE, Schneider DJ.  Platelet reactivity characterized prospectively: a determinant of outcome 90 days after percutaneous coronary intervention.  Circulation 2001; 104:181-186.

Kabbani SS, Watkins MW, Holoch PA, Terrien EF, Sobel BE, Schneider DJ.  Platelet reactivity in coronary ostial blood: a reflection of the thrombotic state accompanying plaque rupture and of the adequacy of anti-thrombotic therapy.  J Thromb Thrombolysis 2001; 12:171-176.

Kabbani SS, Aggarwal A, Terrien EF, DiBattiste PM, Sobel BE, Schneider DJ.  Suboptimal early inhibition of platelets by treatment with tirofiban and implications for coronary interventions.  Am J Cardiol 2002; 89:647-650.

Aggarwal A, Terrien EF, Terrien CM Jr.  Treatment of totally occluded saphenous vein grafts using self-expanding stents.  Coron Artery Dis 2002; 13:373-376.

  Home | Contact Us | Search
      © 1998-2008 Fletcher Allen Health Care, Inc. | Privacy Statement  

 

FAHC home Patients & Visitors Healthcare Providers General Public About FAHC UVM College of Medicine